Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Adenine Dinucleotide, Dihydronicotinamide
2. Coenzyme I
3. Dihydronicotinamide Adenine Dinucleotide
4. Dinucleotide, Dihydronicotinamide Adenine
5. Dinucleotide, Nicotinamide-adenine
6. Diphosphopyridine Nucleotide
7. Dpn
8. Nad
9. Nadh
10. Nadide
11. Nicotinamide Adenine Dinucleotide
12. Nicotinamide-adenine Dinucleotide
13. Nucleotide, Diphosphopyridine
1. Nicotinamide Adenine Dinucleotide
2. Nad+
3. Enzopride
4. Diphosphopyridine Nucleotide
5. 53-84-9
6. Adenine-nicotinamide Dinucleotide
7. Nad
8. Nadidum [inn-latin]
9. Nadida [inn-spanish]
10. Nad(+)
11. Chebi:15846
12. [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl Hydrogen Phosphate
13. 151411-04-0
14. Nicotinamide-adenine Dinucleotide
15. Brn 3584133
16. Sr-05000001677
17. Nadide [usan:ban:inn:jan]
18. Nad Cation
19. [[(2r,3s,4r,5r)-5-[(3r)-3-aminocarbonyl-3,4-dihydro-2h-pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanidyl-phosphoryl] [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl Phosphate
20. 121053-11-0
21. Naj
22. Txe
23. Spectrum_000973
24. Nicotinamide Adenine Dinucleotide (nad+)
25. [[(2~{r},3~{s},4~{r},5~{r})-5-(3-aminocarbonylpyridin-1-ium-1-yl)-4-[[5-[4-cyano-2-[(~{e})-hydroxyiminomethyl]phenoxy]-1-oxidanyl-3~{h}-2,1$l^{4}-benzoxaborol-1-yl]oxy]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{r},3~{s},4~{r},5~{r})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl Hydrogen Phosphate
26. 9jm
27. Adenosine 5'-(trihydrogen Diphosphate), P'-5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt
28. Prestwick3_000741
29. Pyridinium, 3-carbamoyl-1-beta-d-ribofuranosyl-, Hydroxide, 5'-ester With Adenosine 5'-5'-(trihydrogen Pyrophosphate), Inner Salt
30. Spectrum2_001056
31. Spectrum3_000511
32. Spectrum4_000065
33. Spectrum5_001291
34. Bmse000053
35. Nadide (jan/usan/inn)
36. Bspbio_000722
37. Bspbio_002061
38. Kbiogr_000589
39. Kbioss_001453
40. Divk1c_000189
41. Spbio_001012
42. Bpbio1_000796
43. Chembl3039307
44. Schembl14478781
45. Kbio1_000189
46. Kbio2_001453
47. Kbio2_004021
48. Kbio2_006589
49. Kbio3_001561
50. Ninds_000189
51. Zinc8214766
52. Idi1_000189
53. 65085-09-8
54. C00003
55. D00002
56. 036d253
57. Sr-05000001677-1
58. Sr-05000001677-3
59. Brd-a11132253-001-01-7
60. Q26987253
61. 1-[5-o-[(5'-adenylyloxy)phosphonyl]-beta-d-ribofuranosyl]-3-(aminocarbonyl)pyridinium
62. Coconut Oil, Polymer With Benzoic Acid, Glycerol, Pentaerythritol And Phthalic Anhydride
63. 865-05-4
64. Adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-d-ribitol-5-yl] Dihydrogen Diphosphate}
Molecular Weight | 664.4 g/mol |
---|---|
Molecular Formula | C21H28N7O14P2+ |
XLogP3 | -5.9 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 11 |
Exact Mass | 664.11694759 g/mol |
Monoisotopic Mass | 664.11694759 g/mol |
Topological Polar Surface Area | 318 Ų |
Heavy Atom Count | 44 |
Formal Charge | 1 |
Complexity | 1130 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?